You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 6, August 8, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Neurology
 •Stroke
 •Statistics and Research Methods
 •Cardiovascular Disease/ Myocardial Infarction
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Aspirin Dose and Cardiovascular Disease Prevention

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In their systematic review of aspirin dose for the prevention of cardiovascular disease, Dr Campbell and colleagues1 conclude that currently available data do not support the routine long-term use of aspirin dosages greater than 75 mg/d to 81 mg/d in the setting of cardiovascular disease prevention. The definition of cardiovascular disease includes stroke, transient ischemic attack, and myocardial infarction. We agree with the authors that aspirin dosage in excess of 300 mg/d is not justified, but suggest the potential for better stroke prevention using aspirin dosage of 160 mg/d compared with 75 mg/d to 81 mg/d.

Of the 11 studies included in the review, the study by Peters et al2 compared different aspirin dosages in patients with acute coronary syndrome. However, that article only reported the composite outcome of cardiovascular death, myocardial infarction, and stroke. The relationship between aspirin dosage and stroke incidence may be masked by . . . [Full Text of this Article]

George Kwok Chu Wong, MB ChB, FRCSEd(SN)
georgewong@surgery.cuhk.edu.hk
Division of Neurosurgery
The Chinese University of Hong Kong
Hong Kong



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED LETTERS

Aspirin Dose and Cardiovascular Disease Prevention
Andrew Clegg
JAMA. 2007;298(6):625.
EXTRACT | FULL TEXT  

Aspirin Dose and Cardiovascular Disease Prevention—Reply
Charles L. Campbell, Susan Smyth, Steven R. Steinhubl, and Gilles Montalescot
JAMA. 2007;298(6):625-626.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Aspirin Dose for the Prevention of Cardiovascular Disease: A Systematic Review
Charles L. Campbell, Susan Smyth, Gilles Montalescot, and Steven R. Steinhubl
JAMA. 2007;297(18):2018-2024.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.